Ricevi le ultime notizie sulle azioni Calidi Biotherapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CLDI

Ultime notizie per

Calidi Biotherapeutics

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics Inc

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Aprea Therapeutics

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Entero Therapeutics

Evogene

Galecto

HCW Biologics

Imunon

IN8bio

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

BiomX

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sunshine Biopharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Soligenix

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Calidi Biotherapeutics (CLDI) Previsione

Notizie

Utili

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Comments

Calidi Biotherapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO